Clinical Trial Update: The Belgian Genome Resource to Resolve Rare Diseases [NA]

View source ↗

Summary

This completed clinical trial evaluated a Belgian genome resource aimed at resolving rare diseases affecting intellectual development and congenital malformatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Delay
• Dysmorphia
• Intellectual Developmental Disorder
• Malformations

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Intellectual Developmental Disorder, Malformations | NA | Status: COMPLETED